MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
8.18
+0.86 (11.77%)
At close: Dec 5, 2025, 4:00 PM EST
14.30
+6.12 (74.75%)
After-hours: Dec 5, 2025, 7:59 PM EST
MetaVia Market Cap
MetaVia has a market cap or net worth of $18.01 million as of December 5, 2025. Its market cap has decreased by -14.68% in one year.
Market Cap
18.01M
Enterprise Value
3.81M
1-Year Change
-14.68%
Ranking
Category
Stock Price
$8.18
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $18.01M, a decrease of -99.98%. That is a compound annual growth rate of -76.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 18.01M | 2.98% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | 86.24M | -99.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |